Method for Optimizing Blood Cell Transplants

The invention relates to the use of allogenic T lymphocytes for the preparation of a composition intended to be injected into a recipient patient as conditioning for a hematopoietic stem cell transplant, said allogenic T lymphocytes expressing a molecule enabling the specific destruction thereof.

Patents:
WO 2,009,053,631

Inventor(s): KLATZMANN DAVID [FR]; COHEN JOSE [FR]

Type of Offer: Sale



Next Patent »
« More Medical Patents

Share on      


CrowdSell Your Patent